Evidence map›Paper›PMID 35558500›Full record

ArticleRSC advances2018

Structure-dependent antiviral activity of catechol derivatives in pyroligneous acid against the encephalomycarditis virus.

Ruibo Li, Ryo Narita, Ryota Ouda, Chihiro Kimura, Hiroshi Nishimura, Mitsuyoshi Yatagai, Takashi Fujita, Takashi Watanabe

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Ruibo LiResearch Institute for Sustainable Humanosphere, Kyoto University Uji Kyoto 611-0011 Japan twatanab@rish.kyoto-u.ac.jp.
Ryo NaritaResearch Institute for Sustainable Humanosphere, Kyoto University Uji Kyoto 611-0011 Japan twatanab@rish.kyoto-u.ac.jp.
Ryota OudaResearch Institute for Sustainable Humanosphere, Kyoto University Uji Kyoto 611-0011 Japan twatanab@rish.kyoto-u.ac.jp.
Chihiro KimuraResearch Institute for Sustainable Humanosphere, Kyoto University Uji Kyoto 611-0011 Japan twatanab@rish.kyoto-u.ac.jp.
Hiroshi NishimuraResearch Institute for Sustainable Humanosphere, Kyoto University Uji Kyoto 611-0011 Japan twatanab@rish.kyoto-u.ac.jp.
Mitsuyoshi YatagaiTokyo University Hongo, Bunkyo-ku Tokyo 113-8654 Japan.
Takashi FujitaInstitute for Frontier Life and Medical Science, Kyoto University Kyoto 606-8507 Japan.
Takashi WatanabeResearch Institute for Sustainable Humanosphere, Kyoto University Uji Kyoto 611-0011 Japan twatanab@rish.kyoto-u.ac.jp.ORCID https://orcid.org/0000-0003-0220-4157
Kyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pyrolysis product, wood vinegar (WV), from Japanese larch exhibited strong antiviral activity against the encephalomycarditis virus (EMCV). Catechol, 3-methyl-, 4-methyl-, 4-ethyl-, and 3-methoxycatechol, and 2-methyl-1,4-benzenediol were identified as the major antiviral compounds. The viral inhibition ability of these compounds was affected by the structure and position of the substituent group attached to the aromatic skeleton. The IC

Identifiers

PMID35558500
PMCPMC9088284
OpenAlexW2897042812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.